nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—ESR1—urinary bladder cancer	0.73	1	CbGaD
Etonogestrel—CYP3A4—urine—urinary bladder cancer	0.00265	0.107	CbGeAlD
Etonogestrel—SHBG—prostate gland—urinary bladder cancer	0.00242	0.0981	CbGeAlD
Etonogestrel—PGR—prostate gland—urinary bladder cancer	0.00218	0.0883	CbGeAlD
Etonogestrel—ESR1—prostate gland—urinary bladder cancer	0.00171	0.0691	CbGeAlD
Etonogestrel—PGR—epithelium—urinary bladder cancer	0.0016	0.0649	CbGeAlD
Etonogestrel—PGR—smooth muscle tissue—urinary bladder cancer	0.00155	0.0625	CbGeAlD
Etonogestrel—SHBG—female reproductive system—urinary bladder cancer	0.00132	0.0535	CbGeAlD
Etonogestrel—Quinestrol—ESR1—urinary bladder cancer	0.00128	0.201	CrCbGaD
Etonogestrel—ESR1—epithelium—urinary bladder cancer	0.00125	0.0508	CbGeAlD
Etonogestrel—ESR1—smooth muscle tissue—urinary bladder cancer	0.00121	0.0489	CbGeAlD
Etonogestrel—SHBG—vagina—urinary bladder cancer	0.0012	0.0484	CbGeAlD
Etonogestrel—PGR—female reproductive system—urinary bladder cancer	0.00119	0.0482	CbGeAlD
Etonogestrel—ESR1—renal system—urinary bladder cancer	0.00116	0.0471	CbGeAlD
Etonogestrel—PGR—vagina—urinary bladder cancer	0.00108	0.0436	CbGeAlD
Etonogestrel—Mestranol—ESR1—urinary bladder cancer	0.000966	0.152	CrCbGaD
Etonogestrel—Desogestrel—ESR1—urinary bladder cancer	0.000955	0.151	CrCbGaD
Etonogestrel—ESR1—female reproductive system—urinary bladder cancer	0.000932	0.0377	CbGeAlD
Etonogestrel—Norgestimate—ESR1—urinary bladder cancer	0.000893	0.141	CrCbGaD
Etonogestrel—ESR1—vagina—urinary bladder cancer	0.000843	0.0341	CbGeAlD
Etonogestrel—Ethinyl Estradiol—ESR2—urinary bladder cancer	0.000748	0.118	CrCbGaD
Etonogestrel—PGR—lymph node—urinary bladder cancer	0.000697	0.0282	CbGeAlD
Etonogestrel—CYP3A4—renal system—urinary bladder cancer	0.000649	0.0263	CbGeAlD
Etonogestrel—Levonorgestrel—ESR1—urinary bladder cancer	0.000547	0.0862	CrCbGaD
Etonogestrel—ESR1—lymph node—urinary bladder cancer	0.000545	0.0221	CbGeAlD
Etonogestrel—CYP3A4—female reproductive system—urinary bladder cancer	0.00052	0.021	CbGeAlD
Etonogestrel—Danazol—ESR1—urinary bladder cancer	0.000498	0.0785	CrCbGaD
Etonogestrel—Ethinyl Estradiol—ESR1—urinary bladder cancer	0.000461	0.0726	CrCbGaD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—NCOR1—urinary bladder cancer	0.000326	0.00522	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—IGF1—urinary bladder cancer	0.000316	0.00507	CbGpPWpGaD
Etonogestrel—ESR1—FOXM1 transcription factor network—CREBBP—urinary bladder cancer	0.000314	0.00503	CbGpPWpGaD
Etonogestrel—ESR1—FOXM1 transcription factor network—RB1—urinary bladder cancer	0.000313	0.00502	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—S100B—urinary bladder cancer	0.000309	0.00495	CbGpPWpGaD
Etonogestrel—ESR1—FOXA1 transcription factor network—CREBBP—urinary bladder cancer	0.000303	0.00485	CbGpPWpGaD
Etonogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—urinary bladder cancer	0.000298	0.00477	CbGpPWpGaD
Etonogestrel—CYP3A4—Estrogen metabolism—GSTM1—urinary bladder cancer	0.000293	0.00469	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—RB1—urinary bladder cancer	0.000291	0.00466	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—PLAU—urinary bladder cancer	0.00029	0.00465	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—RHOA—urinary bladder cancer	0.00029	0.00464	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000288	0.00462	CbGpPWpGaD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—CCND1—urinary bladder cancer	0.000283	0.00453	CbGpPWpGaD
Etonogestrel—ESR1—Nuclear Receptor transcription pathway—PPARG—urinary bladder cancer	0.00028	0.00449	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—NCOR1—urinary bladder cancer	0.000278	0.00445	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP4B1—urinary bladder cancer	0.000276	0.00442	CbGpPWpGaD
Etonogestrel—ESR1—FOXM1 transcription factor network—CDKN2A—urinary bladder cancer	0.000275	0.00441	CbGpPWpGaD
Etonogestrel—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—urinary bladder cancer	0.000275	0.0044	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—CDK4—urinary bladder cancer	0.000274	0.00439	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—TERT—urinary bladder cancer	0.000274	0.00438	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—NCOR1—urinary bladder cancer	0.00027	0.00432	CbGpPWpGaD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—EP300—urinary bladder cancer	0.00026	0.00417	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—PLAU—urinary bladder cancer	0.000253	0.00406	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—RBX1—urinary bladder cancer	0.00025	0.00401	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—ATM—urinary bladder cancer	0.000246	0.00394	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—PTGS2—urinary bladder cancer	0.000239	0.00383	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—RB1—urinary bladder cancer	0.000239	0.00382	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TSC1—urinary bladder cancer	0.000237	0.00379	CbGpPWpGaD
Etonogestrel—ESR1—FOXM1 transcription factor network—CCND1—urinary bladder cancer	0.000233	0.00372	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—MMP9—urinary bladder cancer	0.00023	0.00369	CbGpPWpGaD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—MYC—urinary bladder cancer	0.000227	0.00363	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—FGFR3—urinary bladder cancer	0.000225	0.0036	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.00022	0.00352	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000219	0.0035	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—ESR1—urinary bladder cancer	0.000218	0.0035	CbGpPWpGaD
Etonogestrel—ESR1—FOXM1 transcription factor network—EP300—urinary bladder cancer	0.000214	0.00343	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—urinary bladder cancer	0.000213	0.00341	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—SRC—urinary bladder cancer	0.000212	0.0034	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—urinary bladder cancer	0.000209	0.00335	CbGpPWpGaD
Etonogestrel—ESR1—FOXA1 transcription factor network—EP300—urinary bladder cancer	0.000206	0.0033	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—EP300—urinary bladder cancer	0.000199	0.00319	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—SRC—urinary bladder cancer	0.000194	0.0031	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—CXCL8—urinary bladder cancer	0.00019	0.00305	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000188	0.00301	CbGpPWpGaD
Etonogestrel—ESR1—FOXM1 transcription factor network—MYC—urinary bladder cancer	0.000187	0.00299	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CREBBP—urinary bladder cancer	0.000186	0.00298	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000185	0.00297	CbGpPWpGaD
Etonogestrel—ESR1—LKB1 signaling events—MYC—urinary bladder cancer	0.000183	0.00293	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—CDKN2A—urinary bladder cancer	0.000183	0.00293	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—S100B—urinary bladder cancer	0.000181	0.00291	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—RHOA—urinary bladder cancer	0.000179	0.00286	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000178	0.00285	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000178	0.00285	CbGpPWpGaD
Etonogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—urinary bladder cancer	0.000177	0.00284	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—CCND1—urinary bladder cancer	0.000177	0.00284	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	0.000176	0.00282	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—KRAS—urinary bladder cancer	0.000176	0.00281	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000176	0.00281	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—MYC—urinary bladder cancer	0.000173	0.00278	CbGpPWpGaD
Etonogestrel—Urticaria—Fluorouracil—urinary bladder cancer	0.000171	0.000968	CcSEcCtD
Etonogestrel—Asthma—Doxorubicin—urinary bladder cancer	0.00017	0.000965	CcSEcCtD
Etonogestrel—Pollakiuria—Epirubicin—urinary bladder cancer	0.00017	0.000963	CcSEcCtD
Etonogestrel—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00017	0.000963	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.00017	0.00272	CbGpPWpGaD
Etonogestrel—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000168	0.000951	CcSEcCtD
Etonogestrel—Paraesthesia—Etoposide—urinary bladder cancer	0.000168	0.00095	CcSEcCtD
Etonogestrel—Weight increased—Epirubicin—urinary bladder cancer	0.000167	0.000949	CcSEcCtD
Etonogestrel—Weight decreased—Epirubicin—urinary bladder cancer	0.000166	0.000943	CcSEcCtD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—urinary bladder cancer	0.000166	0.00266	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—CXCL8—urinary bladder cancer	0.000166	0.00266	CbGpPWpGaD
Etonogestrel—Somnolence—Etoposide—urinary bladder cancer	0.000166	0.00094	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—ERBB2—urinary bladder cancer	0.000166	0.00265	CbGpPWpGaD
Etonogestrel—Vomiting—Thiotepa—urinary bladder cancer	0.000165	0.000936	CcSEcCtD
Etonogestrel—Infestation NOS—Epirubicin—urinary bladder cancer	0.000164	0.00093	CcSEcCtD
Etonogestrel—Infestation—Epirubicin—urinary bladder cancer	0.000164	0.00093	CcSEcCtD
Etonogestrel—Rash—Thiotepa—urinary bladder cancer	0.000164	0.000928	CcSEcCtD
Etonogestrel—Bronchitis—Doxorubicin—urinary bladder cancer	0.000164	0.000928	CcSEcCtD
Etonogestrel—Dermatitis—Thiotepa—urinary bladder cancer	0.000164	0.000928	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—NCOR1—urinary bladder cancer	0.000163	0.00261	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—EP300—urinary bladder cancer	0.000163	0.00261	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000163	0.00261	CbGpPWpGaD
Etonogestrel—Headache—Thiotepa—urinary bladder cancer	0.000163	0.000922	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—IL2—urinary bladder cancer	0.000162	0.0026	CbGpPWpGaD
Etonogestrel—Decreased appetite—Etoposide—urinary bladder cancer	0.000162	0.000919	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000162	0.00259	CbGpPWpGaD
Etonogestrel—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000161	0.000913	CcSEcCtD
Etonogestrel—Body temperature increased—Cisplatin—urinary bladder cancer	0.000161	0.000913	CcSEcCtD
Etonogestrel—Fatigue—Etoposide—urinary bladder cancer	0.000161	0.000912	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000161	0.000911	CcSEcCtD
Etonogestrel—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000161	0.00257	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—ERBB2—urinary bladder cancer	0.00016	0.00257	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.00016	0.00257	CbGpPWpGaD
Etonogestrel—Constipation—Etoposide—urinary bladder cancer	0.00016	0.000905	CcSEcCtD
Etonogestrel—Pain—Etoposide—urinary bladder cancer	0.00016	0.000905	CcSEcCtD
Etonogestrel—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000159	0.000904	CcSEcCtD
Etonogestrel—Dysuria—Doxorubicin—urinary bladder cancer	0.000159	0.000902	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—IL2—urinary bladder cancer	0.000159	0.00254	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000158	0.000897	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—CCND1—urinary bladder cancer	0.000158	0.00253	CbGpPWpGaD
Etonogestrel—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	0.000158	0.000897	CcSEcCtD
Etonogestrel—Haemoglobin—Methotrexate—urinary bladder cancer	0.000158	0.000896	CcSEcCtD
Etonogestrel—Haemorrhage—Methotrexate—urinary bladder cancer	0.000157	0.000892	CcSEcCtD
Etonogestrel—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000157	0.000891	CcSEcCtD
Etonogestrel—Asthenia—Gemcitabine—urinary bladder cancer	0.000157	0.000889	CcSEcCtD
Etonogestrel—Pharyngitis—Methotrexate—urinary bladder cancer	0.000156	0.000885	CcSEcCtD
Etonogestrel—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000155	0.000881	CcSEcCtD
Etonogestrel—Weight increased—Doxorubicin—urinary bladder cancer	0.000155	0.000878	CcSEcCtD
Etonogestrel—Pruritus—Gemcitabine—urinary bladder cancer	0.000155	0.000876	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—CCND1—urinary bladder cancer	0.000155	0.00248	CbGpPWpGaD
Etonogestrel—Nausea—Thiotepa—urinary bladder cancer	0.000154	0.000875	CcSEcCtD
Etonogestrel—Urethral disorder—Methotrexate—urinary bladder cancer	0.000154	0.000874	CcSEcCtD
Etonogestrel—Weight decreased—Doxorubicin—urinary bladder cancer	0.000154	0.000873	CcSEcCtD
Etonogestrel—Sinusitis—Epirubicin—urinary bladder cancer	0.000154	0.000872	CcSEcCtD
Etonogestrel—Feeling abnormal—Etoposide—urinary bladder cancer	0.000154	0.000872	CcSEcCtD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—EP300—urinary bladder cancer	0.000153	0.00245	CbGpPWpGaD
Etonogestrel—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000153	0.000865	CcSEcCtD
Etonogestrel—Pruritus—Fluorouracil—urinary bladder cancer	0.000152	0.000862	CcSEcCtD
Etonogestrel—Infestation—Doxorubicin—urinary bladder cancer	0.000152	0.00086	CcSEcCtD
Etonogestrel—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000152	0.00086	CcSEcCtD
Etonogestrel—Visual impairment—Methotrexate—urinary bladder cancer	0.000152	0.000859	CcSEcCtD
Etonogestrel—ESR1—LKB1 signaling events—TP53—urinary bladder cancer	0.00015	0.00241	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—MMP9—urinary bladder cancer	0.00015	0.0024	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00015	0.000851	CcSEcCtD
Etonogestrel—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000149	0.000848	CcSEcCtD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—HRAS—urinary bladder cancer	0.000149	0.00239	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—PTEN—urinary bladder cancer	0.000149	0.00239	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—ESR2—urinary bladder cancer	0.000149	0.00239	CbGpPWpGaD
Etonogestrel—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000149	0.000843	CcSEcCtD
Etonogestrel—Urticaria—Etoposide—urinary bladder cancer	0.000148	0.00084	CcSEcCtD
Etonogestrel—Haemoglobin—Epirubicin—urinary bladder cancer	0.000148	0.000839	CcSEcCtD
Etonogestrel—Rhinitis—Epirubicin—urinary bladder cancer	0.000148	0.000837	CcSEcCtD
Etonogestrel—Abdominal pain—Etoposide—urinary bladder cancer	0.000147	0.000836	CcSEcCtD
Etonogestrel—Body temperature increased—Etoposide—urinary bladder cancer	0.000147	0.000836	CcSEcCtD
Etonogestrel—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000147	0.000836	CcSEcCtD
Etonogestrel—Haemorrhage—Epirubicin—urinary bladder cancer	0.000147	0.000835	CcSEcCtD
Etonogestrel—Eye disorder—Methotrexate—urinary bladder cancer	0.000147	0.000833	CcSEcCtD
Etonogestrel—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000147	0.000833	CcSEcCtD
Etonogestrel—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000147	0.00235	CbGpPWpGaD
Etonogestrel—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000146	0.00083	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—CCND1—urinary bladder cancer	0.000146	0.00234	CbGpPWpGaD
Etonogestrel—Asthenia—Cisplatin—urinary bladder cancer	0.000146	0.000828	CcSEcCtD
Etonogestrel—Pharyngitis—Epirubicin—urinary bladder cancer	0.000146	0.000828	CcSEcCtD
Etonogestrel—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000145	0.000824	CcSEcCtD
Etonogestrel—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000145	0.00082	CcSEcCtD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000145	0.00232	CbGpPWpGaD
Etonogestrel—Urethral disorder—Epirubicin—urinary bladder cancer	0.000144	0.000818	CcSEcCtD
Etonogestrel—Angiopathy—Methotrexate—urinary bladder cancer	0.000143	0.000809	CcSEcCtD
Etonogestrel—Sinusitis—Doxorubicin—urinary bladder cancer	0.000142	0.000807	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—EP300—urinary bladder cancer	0.000142	0.00228	CbGpPWpGaD
Etonogestrel—Immune system disorder—Methotrexate—urinary bladder cancer	0.000142	0.000805	CcSEcCtD
Etonogestrel—Dizziness—Fluorouracil—urinary bladder cancer	0.000142	0.000805	CcSEcCtD
Etonogestrel—Visual impairment—Epirubicin—urinary bladder cancer	0.000142	0.000804	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	0.00014	0.00224	CbGpPWpGaD
Etonogestrel—Diarrhoea—Cisplatin—urinary bladder cancer	0.000139	0.00079	CcSEcCtD
Etonogestrel—Alopecia—Methotrexate—urinary bladder cancer	0.000139	0.000788	CcSEcCtD
Etonogestrel—Vomiting—Gemcitabine—urinary bladder cancer	0.000139	0.000788	CcSEcCtD
Etonogestrel—Mental disorder—Methotrexate—urinary bladder cancer	0.000138	0.000781	CcSEcCtD
Etonogestrel—Rash—Gemcitabine—urinary bladder cancer	0.000138	0.000781	CcSEcCtD
Etonogestrel—Dermatitis—Gemcitabine—urinary bladder cancer	0.000138	0.00078	CcSEcCtD
Etonogestrel—Eye disorder—Epirubicin—urinary bladder cancer	0.000138	0.00078	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	0.000137	0.0022	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Etoposide—urinary bladder cancer	0.000137	0.000779	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—CDKN1A—urinary bladder cancer	0.000137	0.00219	CbGpPWpGaD
Etonogestrel—Malnutrition—Methotrexate—urinary bladder cancer	0.000137	0.000776	CcSEcCtD
Etonogestrel—Erythema—Methotrexate—urinary bladder cancer	0.000137	0.000776	CcSEcCtD
Etonogestrel—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000137	0.000776	CcSEcCtD
Etonogestrel—Headache—Gemcitabine—urinary bladder cancer	0.000137	0.000776	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—PTEN—urinary bladder cancer	0.000137	0.00219	CbGpPWpGaD
Etonogestrel—Vomiting—Fluorouracil—urinary bladder cancer	0.000137	0.000774	CcSEcCtD
Etonogestrel—Rhinitis—Doxorubicin—urinary bladder cancer	0.000137	0.000774	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	0.000136	0.00218	CbGpPWpGaD
Etonogestrel—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000136	0.000772	CcSEcCtD
Etonogestrel—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000135	0.000768	CcSEcCtD
Etonogestrel—Rash—Fluorouracil—urinary bladder cancer	0.000135	0.000768	CcSEcCtD
Etonogestrel—Dermatitis—Fluorouracil—urinary bladder cancer	0.000135	0.000767	CcSEcCtD
Etonogestrel—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000135	0.000766	CcSEcCtD
Etonogestrel—Headache—Fluorouracil—urinary bladder cancer	0.000135	0.000763	CcSEcCtD
Etonogestrel—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000134	0.000763	CcSEcCtD
Etonogestrel—Asthenia—Etoposide—urinary bladder cancer	0.000134	0.000759	CcSEcCtD
Etonogestrel—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.000134	0.000759	CcSEcCtD
Etonogestrel—Angiopathy—Epirubicin—urinary bladder cancer	0.000134	0.000757	CcSEcCtD
Etonogestrel—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000133	0.000757	CcSEcCtD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—MYC—urinary bladder cancer	0.000133	0.00213	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—urinary bladder cancer	0.000133	0.00213	CbGpPWpGaD
Etonogestrel—Immune system disorder—Epirubicin—urinary bladder cancer	0.000133	0.000754	CcSEcCtD
Etonogestrel—Back pain—Methotrexate—urinary bladder cancer	0.000132	0.000751	CcSEcCtD
Etonogestrel—Pruritus—Etoposide—urinary bladder cancer	0.000132	0.000748	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—FGFR3—urinary bladder cancer	0.000132	0.00211	CbGpPWpGaD
Etonogestrel—Visual impairment—Doxorubicin—urinary bladder cancer	0.000131	0.000744	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—SRC—urinary bladder cancer	0.000131	0.0021	CbGpPWpGaD
Etonogestrel—Alopecia—Epirubicin—urinary bladder cancer	0.00013	0.000737	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—ATM—urinary bladder cancer	0.00013	0.00208	CbGpPWpGaD
Etonogestrel—Nausea—Gemcitabine—urinary bladder cancer	0.00013	0.000736	CcSEcCtD
Etonogestrel—Vomiting—Cisplatin—urinary bladder cancer	0.000129	0.000734	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CDK4—urinary bladder cancer	0.000129	0.00207	CbGpPWpGaD
Etonogestrel—Mental disorder—Epirubicin—urinary bladder cancer	0.000129	0.000731	CcSEcCtD
Etonogestrel—Rash—Cisplatin—urinary bladder cancer	0.000128	0.000728	CcSEcCtD
Etonogestrel—Dermatitis—Cisplatin—urinary bladder cancer	0.000128	0.000727	CcSEcCtD
Etonogestrel—Erythema—Epirubicin—urinary bladder cancer	0.000128	0.000726	CcSEcCtD
Etonogestrel—Malnutrition—Epirubicin—urinary bladder cancer	0.000128	0.000726	CcSEcCtD
Etonogestrel—Diarrhoea—Etoposide—urinary bladder cancer	0.000128	0.000724	CcSEcCtD
Etonogestrel—Nausea—Fluorouracil—urinary bladder cancer	0.000128	0.000723	CcSEcCtD
Etonogestrel—Eye disorder—Doxorubicin—urinary bladder cancer	0.000127	0.000722	CcSEcCtD
Etonogestrel—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000127	0.00072	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—MYC—urinary bladder cancer	0.000127	0.00203	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—urinary bladder cancer	0.000127	0.00203	CbGpPWpGaD
Etonogestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000126	0.00202	CbGpPWpGaD
Etonogestrel—Flatulence—Epirubicin—urinary bladder cancer	0.000126	0.000716	CcSEcCtD
Etonogestrel—Tension—Epirubicin—urinary bladder cancer	0.000126	0.000713	CcSEcCtD
Etonogestrel—Nervousness—Epirubicin—urinary bladder cancer	0.000124	0.000706	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—EGFR—urinary bladder cancer	0.000124	0.00199	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—MYC—urinary bladder cancer	0.000124	0.00199	CbGpPWpGaD
Etonogestrel—Back pain—Epirubicin—urinary bladder cancer	0.000124	0.000703	CcSEcCtD
Etonogestrel—Angiopathy—Doxorubicin—urinary bladder cancer	0.000124	0.000701	CcSEcCtD
Etonogestrel—Malaise—Methotrexate—urinary bladder cancer	0.000123	0.0007	CcSEcCtD
Etonogestrel—Dizziness—Etoposide—urinary bladder cancer	0.000123	0.000699	CcSEcCtD
Etonogestrel—Muscle spasms—Epirubicin—urinary bladder cancer	0.000123	0.000698	CcSEcCtD
Etonogestrel—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000123	0.000697	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	0.000122	0.00195	CbGpPWpGaD
Etonogestrel—Nausea—Cisplatin—urinary bladder cancer	0.000121	0.000686	CcSEcCtD
Etonogestrel—Alopecia—Doxorubicin—urinary bladder cancer	0.00012	0.000682	CcSEcCtD
Etonogestrel—Cough—Methotrexate—urinary bladder cancer	0.000119	0.000677	CcSEcCtD
Etonogestrel—Mental disorder—Doxorubicin—urinary bladder cancer	0.000119	0.000677	CcSEcCtD
Etonogestrel—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000119	0.000674	CcSEcCtD
Etonogestrel—Convulsion—Methotrexate—urinary bladder cancer	0.000119	0.000673	CcSEcCtD
Etonogestrel—Vomiting—Etoposide—urinary bladder cancer	0.000119	0.000673	CcSEcCtD
Etonogestrel—Malnutrition—Doxorubicin—urinary bladder cancer	0.000119	0.000672	CcSEcCtD
Etonogestrel—Erythema—Doxorubicin—urinary bladder cancer	0.000119	0.000672	CcSEcCtD
Etonogestrel—Rash—Etoposide—urinary bladder cancer	0.000118	0.000667	CcSEcCtD
Etonogestrel—Dermatitis—Etoposide—urinary bladder cancer	0.000118	0.000666	CcSEcCtD
Etonogestrel—Headache—Etoposide—urinary bladder cancer	0.000117	0.000663	CcSEcCtD
Etonogestrel—Flatulence—Doxorubicin—urinary bladder cancer	0.000117	0.000662	CcSEcCtD
Etonogestrel—Arthralgia—Methotrexate—urinary bladder cancer	0.000117	0.000661	CcSEcCtD
Etonogestrel—Myalgia—Methotrexate—urinary bladder cancer	0.000117	0.000661	CcSEcCtD
Etonogestrel—Tension—Doxorubicin—urinary bladder cancer	0.000116	0.00066	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000116	0.000656	CcSEcCtD
Etonogestrel—Malaise—Epirubicin—urinary bladder cancer	0.000116	0.000655	CcSEcCtD
Etonogestrel—Discomfort—Methotrexate—urinary bladder cancer	0.000115	0.000653	CcSEcCtD
Etonogestrel—Nervousness—Doxorubicin—urinary bladder cancer	0.000115	0.000653	CcSEcCtD
Etonogestrel—PGR—Generic Transcription Pathway—NCOR1—urinary bladder cancer	0.000115	0.00184	CbGpPWpGaD
Etonogestrel—Back pain—Doxorubicin—urinary bladder cancer	0.000115	0.00065	CcSEcCtD
Etonogestrel—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000114	0.000646	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—RB1—urinary bladder cancer	0.000112	0.0018	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CDH1—urinary bladder cancer	0.000112	0.0018	CbGpPWpGaD
Etonogestrel—Cough—Epirubicin—urinary bladder cancer	0.000112	0.000634	CcSEcCtD
Etonogestrel—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000112	0.000634	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—EGFR—urinary bladder cancer	0.000111	0.00178	CbGpPWpGaD
Etonogestrel—Convulsion—Epirubicin—urinary bladder cancer	0.000111	0.000629	CcSEcCtD
Etonogestrel—Infection—Methotrexate—urinary bladder cancer	0.000111	0.000629	CcSEcCtD
Etonogestrel—Nausea—Etoposide—urinary bladder cancer	0.000111	0.000628	CcSEcCtD
Etonogestrel—Hypertension—Epirubicin—urinary bladder cancer	0.000111	0.000627	CcSEcCtD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—urinary bladder cancer	0.00011	0.00177	CbGpPWpGaD
Etonogestrel—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00011	0.000624	CcSEcCtD
Etonogestrel—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00011	0.000621	CcSEcCtD
Etonogestrel—Myalgia—Epirubicin—urinary bladder cancer	0.000109	0.000619	CcSEcCtD
Etonogestrel—Arthralgia—Epirubicin—urinary bladder cancer	0.000109	0.000619	CcSEcCtD
Etonogestrel—Anxiety—Epirubicin—urinary bladder cancer	0.000109	0.000616	CcSEcCtD
Etonogestrel—Skin disorder—Methotrexate—urinary bladder cancer	0.000109	0.000615	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000108	0.000614	CcSEcCtD
Etonogestrel—Discomfort—Epirubicin—urinary bladder cancer	0.000108	0.000611	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	0.000108	0.00172	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	0.000107	0.00172	CbGpPWpGaD
Etonogestrel—Malaise—Doxorubicin—urinary bladder cancer	0.000107	0.000606	CcSEcCtD
Etonogestrel—Anorexia—Methotrexate—urinary bladder cancer	0.000107	0.000604	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—KRAS—urinary bladder cancer	0.000105	0.00168	CbGpPWpGaD
Etonogestrel—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000105	0.000593	CcSEcCtD
Etonogestrel—Oedema—Epirubicin—urinary bladder cancer	0.000105	0.000593	CcSEcCtD
Etonogestrel—Infection—Epirubicin—urinary bladder cancer	0.000104	0.000589	CcSEcCtD
Etonogestrel—Cough—Doxorubicin—urinary bladder cancer	0.000103	0.000587	CcSEcCtD
Etonogestrel—Convulsion—Doxorubicin—urinary bladder cancer	0.000103	0.000582	CcSEcCtD
Etonogestrel—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000103	0.000581	CcSEcCtD
Etonogestrel—Hypertension—Doxorubicin—urinary bladder cancer	0.000102	0.00058	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000102	0.000577	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—TP53—urinary bladder cancer	0.000102	0.00163	CbGpPWpGaD
Etonogestrel—Skin disorder—Epirubicin—urinary bladder cancer	0.000102	0.000576	CcSEcCtD
Etonogestrel—Insomnia—Methotrexate—urinary bladder cancer	0.000101	0.000573	CcSEcCtD
Etonogestrel—Arthralgia—Doxorubicin—urinary bladder cancer	0.000101	0.000572	CcSEcCtD
Etonogestrel—Myalgia—Doxorubicin—urinary bladder cancer	0.000101	0.000572	CcSEcCtD
Etonogestrel—Anxiety—Doxorubicin—urinary bladder cancer	0.000101	0.00057	CcSEcCtD
Etonogestrel—Paraesthesia—Methotrexate—urinary bladder cancer	0.0001	0.000569	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.0001	0.000568	CcSEcCtD
Etonogestrel—Discomfort—Doxorubicin—urinary bladder cancer	9.97e-05	0.000565	CcSEcCtD
Etonogestrel—Anorexia—Epirubicin—urinary bladder cancer	9.97e-05	0.000565	CcSEcCtD
Etonogestrel—Somnolence—Methotrexate—urinary bladder cancer	9.93e-05	0.000563	CcSEcCtD
Etonogestrel—Dyspepsia—Methotrexate—urinary bladder cancer	9.84e-05	0.000558	CcSEcCtD
Etonogestrel—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	9.75e-05	0.00156	CbGpPWpGaD
Etonogestrel—Decreased appetite—Methotrexate—urinary bladder cancer	9.71e-05	0.000551	CcSEcCtD
Etonogestrel—Anaphylactic shock—Doxorubicin—urinary bladder cancer	9.68e-05	0.000549	CcSEcCtD
Etonogestrel—Oedema—Doxorubicin—urinary bladder cancer	9.68e-05	0.000549	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	9.65e-05	0.000547	CcSEcCtD
Etonogestrel—Fatigue—Methotrexate—urinary bladder cancer	9.63e-05	0.000546	CcSEcCtD
Etonogestrel—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	9.62e-05	0.00154	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HDAC4—urinary bladder cancer	9.62e-05	0.00154	CbGpPWpGaD
Etonogestrel—Infection—Doxorubicin—urinary bladder cancer	9.61e-05	0.000545	CcSEcCtD
Etonogestrel—Pain—Methotrexate—urinary bladder cancer	9.55e-05	0.000542	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	9.53e-05	0.00054	CcSEcCtD
Etonogestrel—Nervous system disorder—Doxorubicin—urinary bladder cancer	9.49e-05	0.000538	CcSEcCtD
Etonogestrel—Insomnia—Epirubicin—urinary bladder cancer	9.46e-05	0.000536	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—ERBB2—urinary bladder cancer	9.41e-05	0.00151	CbGpPWpGaD
Etonogestrel—Skin disorder—Doxorubicin—urinary bladder cancer	9.4e-05	0.000533	CcSEcCtD
Etonogestrel—Paraesthesia—Epirubicin—urinary bladder cancer	9.39e-05	0.000532	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	9.36e-05	0.0015	CbGpPWpGaD
Etonogestrel—Somnolence—Epirubicin—urinary bladder cancer	9.3e-05	0.000527	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	9.24e-05	0.00148	CbGpPWpGaD
Etonogestrel—Anorexia—Doxorubicin—urinary bladder cancer	9.22e-05	0.000523	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—HRAS—urinary bladder cancer	9.21e-05	0.00148	CbGpPWpGaD
Etonogestrel—Feeling abnormal—Methotrexate—urinary bladder cancer	9.21e-05	0.000522	CcSEcCtD
Etonogestrel—Dyspepsia—Epirubicin—urinary bladder cancer	9.2e-05	0.000522	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Methotrexate—urinary bladder cancer	9.14e-05	0.000518	CcSEcCtD
Etonogestrel—Decreased appetite—Epirubicin—urinary bladder cancer	9.09e-05	0.000515	CcSEcCtD
Etonogestrel—PGR—Generic Transcription Pathway—ESR1—urinary bladder cancer	9.04e-05	0.00145	CbGpPWpGaD
Etonogestrel—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	9.03e-05	0.000512	CcSEcCtD
Etonogestrel—Fatigue—Epirubicin—urinary bladder cancer	9.02e-05	0.000511	CcSEcCtD
Etonogestrel—Constipation—Epirubicin—urinary bladder cancer	8.94e-05	0.000507	CcSEcCtD
Etonogestrel—Pain—Epirubicin—urinary bladder cancer	8.94e-05	0.000507	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—HRAS—urinary bladder cancer	8.92e-05	0.00143	CbGpPWpGaD
Etonogestrel—Urticaria—Methotrexate—urinary bladder cancer	8.88e-05	0.000503	CcSEcCtD
Etonogestrel—Abdominal pain—Methotrexate—urinary bladder cancer	8.83e-05	0.000501	CcSEcCtD
Etonogestrel—Body temperature increased—Methotrexate—urinary bladder cancer	8.83e-05	0.000501	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	8.81e-05	0.0005	CcSEcCtD
Etonogestrel—Insomnia—Doxorubicin—urinary bladder cancer	8.75e-05	0.000496	CcSEcCtD
Etonogestrel—ESR1—Generic Transcription Pathway—ESR2—urinary bladder cancer	8.74e-05	0.0014	CbGpPWpGaD
Etonogestrel—Paraesthesia—Doxorubicin—urinary bladder cancer	8.69e-05	0.000493	CcSEcCtD
Etonogestrel—Feeling abnormal—Epirubicin—urinary bladder cancer	8.62e-05	0.000489	CcSEcCtD
Etonogestrel—Somnolence—Doxorubicin—urinary bladder cancer	8.6e-05	0.000488	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Epirubicin—urinary bladder cancer	8.55e-05	0.000485	CcSEcCtD
Etonogestrel—Dyspepsia—Doxorubicin—urinary bladder cancer	8.52e-05	0.000483	CcSEcCtD
Etonogestrel—Decreased appetite—Doxorubicin—urinary bladder cancer	8.41e-05	0.000477	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CCND1—urinary bladder cancer	8.35e-05	0.00134	CbGpPWpGaD
Etonogestrel—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	8.35e-05	0.000474	CcSEcCtD
Etonogestrel—Fatigue—Doxorubicin—urinary bladder cancer	8.34e-05	0.000473	CcSEcCtD
Etonogestrel—Urticaria—Epirubicin—urinary bladder cancer	8.31e-05	0.000471	CcSEcCtD
Etonogestrel—Constipation—Doxorubicin—urinary bladder cancer	8.27e-05	0.000469	CcSEcCtD
Etonogestrel—Pain—Doxorubicin—urinary bladder cancer	8.27e-05	0.000469	CcSEcCtD
Etonogestrel—Abdominal pain—Epirubicin—urinary bladder cancer	8.27e-05	0.000469	CcSEcCtD
Etonogestrel—Body temperature increased—Epirubicin—urinary bladder cancer	8.27e-05	0.000469	CcSEcCtD
Etonogestrel—PGR—Generic Transcription Pathway—PPARG—urinary bladder cancer	8.24e-05	0.00132	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Methotrexate—urinary bladder cancer	8.23e-05	0.000467	CcSEcCtD
Etonogestrel—PGR—Gene Expression—SMC1A—urinary bladder cancer	8.23e-05	0.00132	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—PTEN—urinary bladder cancer	8.06e-05	0.00129	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—GLI1—urinary bladder cancer	8.06e-05	0.00129	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—CDKN1A—urinary bladder cancer	8.04e-05	0.00129	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PTEN—urinary bladder cancer	8.02e-05	0.00128	CbGpPWpGaD
Etonogestrel—Asthenia—Methotrexate—urinary bladder cancer	8.02e-05	0.000455	CcSEcCtD
Etonogestrel—Feeling abnormal—Doxorubicin—urinary bladder cancer	7.97e-05	0.000452	CcSEcCtD
Etonogestrel—PGR—Generic Transcription Pathway—CREBBP—urinary bladder cancer	7.92e-05	0.00127	CbGpPWpGaD
Etonogestrel—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	7.91e-05	0.000449	CcSEcCtD
Etonogestrel—Pruritus—Methotrexate—urinary bladder cancer	7.91e-05	0.000448	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	7.84e-05	0.00125	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	7.8e-05	0.00125	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Epirubicin—urinary bladder cancer	7.7e-05	0.000437	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—EP300—urinary bladder cancer	7.69e-05	0.00123	CbGpPWpGaD
Etonogestrel—Urticaria—Doxorubicin—urinary bladder cancer	7.69e-05	0.000436	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	7.66e-05	0.00123	CbGpPWpGaD
Etonogestrel—Abdominal pain—Doxorubicin—urinary bladder cancer	7.65e-05	0.000434	CcSEcCtD
Etonogestrel—Body temperature increased—Doxorubicin—urinary bladder cancer	7.65e-05	0.000434	CcSEcCtD
Etonogestrel—Diarrhoea—Methotrexate—urinary bladder cancer	7.64e-05	0.000433	CcSEcCtD
Etonogestrel—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	7.56e-05	0.00121	CbGpPWpGaD
Etonogestrel—Asthenia—Epirubicin—urinary bladder cancer	7.5e-05	0.000425	CcSEcCtD
Etonogestrel—Pruritus—Epirubicin—urinary bladder cancer	7.4e-05	0.000419	CcSEcCtD
Etonogestrel—Dizziness—Methotrexate—urinary bladder cancer	7.39e-05	0.000419	CcSEcCtD
Etonogestrel—PGR—Gene Expression—ESR2—urinary bladder cancer	7.17e-05	0.00115	CbGpPWpGaD
Etonogestrel—Diarrhoea—Epirubicin—urinary bladder cancer	7.15e-05	0.000406	CcSEcCtD
Etonogestrel—Hypersensitivity—Doxorubicin—urinary bladder cancer	7.13e-05	0.000404	CcSEcCtD
Etonogestrel—Vomiting—Methotrexate—urinary bladder cancer	7.1e-05	0.000403	CcSEcCtD
Etonogestrel—Rash—Methotrexate—urinary bladder cancer	7.05e-05	0.000399	CcSEcCtD
Etonogestrel—Dermatitis—Methotrexate—urinary bladder cancer	7.04e-05	0.000399	CcSEcCtD
Etonogestrel—Headache—Methotrexate—urinary bladder cancer	7e-05	0.000397	CcSEcCtD
Etonogestrel—Asthenia—Doxorubicin—urinary bladder cancer	6.94e-05	0.000394	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	6.92e-05	0.00111	CbGpPWpGaD
Etonogestrel—Dizziness—Epirubicin—urinary bladder cancer	6.91e-05	0.000392	CcSEcCtD
Etonogestrel—Pruritus—Doxorubicin—urinary bladder cancer	6.85e-05	0.000388	CcSEcCtD
Etonogestrel—ESR1—Generic Transcription Pathway—NCOR1—urinary bladder cancer	6.75e-05	0.00108	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MYC—urinary bladder cancer	6.7e-05	0.00107	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	6.7e-05	0.00107	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	6.68e-05	0.00107	CbGpPWpGaD
Etonogestrel—Vomiting—Epirubicin—urinary bladder cancer	6.65e-05	0.000377	CcSEcCtD
Etonogestrel—Nausea—Methotrexate—urinary bladder cancer	6.64e-05	0.000376	CcSEcCtD
Etonogestrel—Diarrhoea—Doxorubicin—urinary bladder cancer	6.62e-05	0.000375	CcSEcCtD
Etonogestrel—Rash—Epirubicin—urinary bladder cancer	6.59e-05	0.000374	CcSEcCtD
Etonogestrel—Dermatitis—Epirubicin—urinary bladder cancer	6.59e-05	0.000373	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—urinary bladder cancer	6.55e-05	0.00105	CbGpPWpGaD
Etonogestrel—Headache—Epirubicin—urinary bladder cancer	6.55e-05	0.000371	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—EGFR—urinary bladder cancer	6.52e-05	0.00104	CbGpPWpGaD
Etonogestrel—Dizziness—Doxorubicin—urinary bladder cancer	6.4e-05	0.000363	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	6.37e-05	0.00102	CbGpPWpGaD
Etonogestrel—Nausea—Epirubicin—urinary bladder cancer	6.21e-05	0.000352	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	6.2e-05	0.000992	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	6.19e-05	0.000992	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—KRAS—urinary bladder cancer	6.16e-05	0.000987	CbGpPWpGaD
Etonogestrel—Vomiting—Doxorubicin—urinary bladder cancer	6.15e-05	0.000349	CcSEcCtD
Etonogestrel—Rash—Doxorubicin—urinary bladder cancer	6.1e-05	0.000346	CcSEcCtD
Etonogestrel—Dermatitis—Doxorubicin—urinary bladder cancer	6.09e-05	0.000346	CcSEcCtD
Etonogestrel—Headache—Doxorubicin—urinary bladder cancer	6.06e-05	0.000344	CcSEcCtD
Etonogestrel—Nausea—Doxorubicin—urinary bladder cancer	5.75e-05	0.000326	CcSEcCtD
Etonogestrel—ESR1—Signaling Pathways—HDAC4—urinary bladder cancer	5.65e-05	0.000904	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	5.55e-05	0.000889	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NCOR1—urinary bladder cancer	5.54e-05	0.000887	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RBX1—urinary bladder cancer	5.53e-05	0.000885	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	5.5e-05	0.000881	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	5.43e-05	0.00087	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	5.24e-05	0.00084	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—HRAS—urinary bladder cancer	5.24e-05	0.000839	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—ERCC2—urinary bladder cancer	5.21e-05	0.000834	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TSC1—urinary bladder cancer	5.19e-05	0.000832	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	5.17e-05	0.000828	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	5.17e-05	0.000828	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	5.13e-05	0.000822	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—JAG1—urinary bladder cancer	4.95e-05	0.000792	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—PPARG—urinary bladder cancer	4.84e-05	0.000775	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—SMC1A—urinary bladder cancer	4.83e-05	0.000774	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	4.82e-05	0.000772	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.75e-05	0.000761	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—GLI1—urinary bladder cancer	4.73e-05	0.000758	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—MYC—urinary bladder cancer	4.7e-05	0.000753	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	4.65e-05	0.000744	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	4.56e-05	0.00073	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—ESR1—urinary bladder cancer	4.35e-05	0.000697	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—ESR2—urinary bladder cancer	4.21e-05	0.000674	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—S100B—urinary bladder cancer	4e-05	0.000641	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—PPARG—urinary bladder cancer	3.97e-05	0.000636	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—CREBBP—urinary bladder cancer	3.81e-05	0.000611	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NCOR1—urinary bladder cancer	3.6e-05	0.000577	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NCOR1—urinary bladder cancer	3.25e-05	0.000521	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RBX1—urinary bladder cancer	3.24e-05	0.000519	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.21e-05	0.000514	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TERT—urinary bladder cancer	3.17e-05	0.000508	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—ERCC2—urinary bladder cancer	3.06e-05	0.000489	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TSC1—urinary bladder cancer	3.05e-05	0.000488	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.04e-05	0.000488	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.04e-05	0.000488	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FGFR3—urinary bladder cancer	2.91e-05	0.000466	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—JAG1—urinary bladder cancer	2.9e-05	0.000465	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ESR1—urinary bladder cancer	2.83e-05	0.000453	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.78e-05	0.000446	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—MYC—urinary bladder cancer	2.76e-05	0.000442	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.51e-05	0.000402	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CREBBP—urinary bladder cancer	2.48e-05	0.000397	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IGF1—urinary bladder cancer	2.45e-05	0.000392	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.37e-05	0.000379	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—S100B—urinary bladder cancer	2.35e-05	0.000376	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—PPARG—urinary bladder cancer	2.33e-05	0.000373	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.31e-05	0.00037	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MYC—urinary bladder cancer	2.26e-05	0.000362	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RHOA—urinary bladder cancer	2.24e-05	0.000359	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—CREBBP—urinary bladder cancer	2.24e-05	0.000358	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NCOR1—urinary bladder cancer	2.11e-05	0.000338	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ERBB2—urinary bladder cancer	2.08e-05	0.000333	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CXCL8—urinary bladder cancer	1.97e-05	0.000315	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL2—urinary bladder cancer	1.88e-05	0.000301	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TERT—urinary bladder cancer	1.86e-05	0.000298	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.84e-05	0.000295	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCND1—urinary bladder cancer	1.83e-05	0.000294	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MMP9—urinary bladder cancer	1.78e-05	0.000285	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN1A—urinary bladder cancer	1.77e-05	0.000284	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTEN—urinary bladder cancer	1.77e-05	0.000284	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FGFR3—urinary bladder cancer	1.71e-05	0.000274	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EP300—urinary bladder cancer	1.69e-05	0.00027	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.67e-05	0.000267	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SRC—urinary bladder cancer	1.64e-05	0.000263	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MYC—urinary bladder cancer	1.47e-05	0.000236	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CREBBP—urinary bladder cancer	1.45e-05	0.000233	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.44e-05	0.000231	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EGFR—urinary bladder cancer	1.44e-05	0.00023	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IGF1—urinary bladder cancer	1.44e-05	0.00023	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KRAS—urinary bladder cancer	1.36e-05	0.000218	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.33e-05	0.000214	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.33e-05	0.000214	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MYC—urinary bladder cancer	1.33e-05	0.000213	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RHOA—urinary bladder cancer	1.32e-05	0.000211	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.29e-05	0.000207	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ERBB2—urinary bladder cancer	1.22e-05	0.000195	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TP53—urinary bladder cancer	1.21e-05	0.000194	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCL8—urinary bladder cancer	1.16e-05	0.000185	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HRAS—urinary bladder cancer	1.16e-05	0.000185	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL2—urinary bladder cancer	1.1e-05	0.000177	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCND1—urinary bladder cancer	1.08e-05	0.000172	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.07e-05	0.000172	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MMP9—urinary bladder cancer	1.05e-05	0.000167	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN1A—urinary bladder cancer	1.04e-05	0.000167	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTEN—urinary bladder cancer	1.04e-05	0.000166	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EP300—urinary bladder cancer	9.91e-06	0.000159	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SRC—urinary bladder cancer	9.64e-06	0.000154	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	8.97e-06	0.000144	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MYC—urinary bladder cancer	8.63e-06	0.000138	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EGFR—urinary bladder cancer	8.45e-06	0.000135	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—TYMS—urinary bladder cancer	8.33e-06	0.000133	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	8.24e-06	0.000132	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	8.24e-06	0.000132	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KRAS—urinary bladder cancer	7.98e-06	0.000128	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GPX1—urinary bladder cancer	7.89e-06	0.000126	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	7.75e-06	0.000124	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	7.28e-06	0.000117	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TP53—urinary bladder cancer	7.09e-06	0.000114	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HRAS—urinary bladder cancer	6.78e-06	0.000109	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PPARG—urinary bladder cancer	5.9e-06	9.46e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	5.67e-06	9.08e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.64e-06	7.44e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.05e-06	6.49e-05	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.86e-06	6.19e-05	CbGpPWpGaD
